Other
Pain Relief Cream
Pain Relief Cream
FDA Label NDC 84023-301
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Yangan Technology Co., Ltd. for the product Pain Relief Cream (NDC 84023-301). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Active Ingredient
Lidocaine 4%
Otc - Purpose
Topical Anesthetic
Indications & Usage
For the temporary relief of minor aches and pains of muscles and joints, associated with simple backache, arthritis, strains, bruises, and sprains.
Warnings
For external use only
Otc - Do Not Use
on damaged or broken skin.
Otc - When Using
Avoid contact with the eyes.
Do notbandage tightly.
Otc - Stop Use
rash or irritation develops and lasts.
condition worsens, or if symptoms persist for more than 7 days or dearup and occur again within a few days.
Otc - Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use
Dosage & Administration
Adults and children 2 years of age and older: Apply to affected area notmore than 3 to 4 times daily.
Children under 2 years of age: consult a doctor.
Storage And Handling
Protect the product in this container from excessive heat and direct sun.
Inactive Ingredient
Aloe barbadebsis leaf juice (Aloe vera)
Water
Lecithin (Soybean)
Propylene Glycol
Tocopheryl Acetate
Carbomer
Menthol
Triethanolamine
Package Label.Principal Display Panel
Label-3 (Label 3)
* Please review the disclaimer below.
